MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$150.67
−1.10%Forward multiples
Based on analyst estimates
- P/E forward
- 17.47x
- P/E 2026E
- 55.31x
- P/E 2027E
- 15.93x
- P/E 2028E
- 14.44x
- P/S forward
- 5.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 119.58x
- PEG TTM
- 0.21x
- Price / book
- 8.86x
- Price / sales
- 5.60x
- Price / cash flow
- 18.62x
Enterprise value
- Enterprise value
- $418.5B
- EV / sales
- 6.30x
- EV / EBITDA
- 30.23x
- EV / EBIT
- 37.86x
- Market cap
- $371.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026